A. D. Webster
Research Subjects
A. D. Webster has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
M. Raeiszadeh
Centre for Immunology, Hampstead Campus, Royal Free and University College Medical School, London, UK
2 shared publicationsS. Workman
Centre for Immunology, Hampstead Campus, Royal Free and University College Medical School, London
2 shared publicationsA. D. Hislop
Institute for Cancer Studies and MRC Centre for Immune Regulation, University of Birmingham, UK
1 shared publicationA. Dodi
Anthony Nolan Centre, Pond Street, London
1 shared publicationG. A. D. Hardy
Centre for Immunology, Hampstead Campus, Royal Free and University College Medical School, London
1 shared publicationJ. Kopycinski
Department of Infection, Hampstead Campus, Royal Free and University College Medical School, London
1 shared publication
Latest Publications
- Open Access
- 27 September 2006
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 146 (2) , 234-242
The T cell response to persistent herpes virus infections in common variable immunodeficiency
We show that at least half of patients with common variable immunodeficiency (CVID) have circulating CD8+ T cells specific for epitopes derived from cytomegalovirus (CMV) and/or the Epstein–Barr virus (EBV). Compared to healthy age-matched subjects, more CD8+ T cells in CVID patients were committed to CMV. Despite previous reports of defects in antigen presentation and cellular immunity in CVID, specific CD4+ and CD8+ T cells produced interferon (IFN)-γ after stimulation with CMV peptides, and peripheral blood mononuclear cells secreted perforin in response to these antigens. In CVID patients we found an association between a high percentage of circulating CD8+ CD57+ T cells containing perforin, CMV infection and a low CD4/CD8 ratio, suggesting that CMV may have a major role in the T cell abnormalities described previously in this disease. We also show preliminary evidence that CMV contributes to the previously unexplained severe enteropathy that occurs in about 5% of patients.
- 27 September 2006
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 146 (2) , 234-242
Open AccessThe T cell response to persistent herpes virus infections in common variable immunodeficiency
We show that at least half of patients with common variable immunodeficiency (CVID) have circulating CD8+ T cells specific for epitopes derived from cytomegalovirus (CMV) and/or the Epstein–Barr virus (EBV). Compared to healthy age-matched subjects, more CD8+ T cells in CVID patients were committed to CMV. Despite previous reports of defects in antigen presentation and cellular immunity in CVID, specific CD4+ and CD8+ T cells produced interferon (IFN)-γ after stimulation with CMV peptides, and peripheral blood mononuclear cells secreted perforin in response to these antigens. In CVID patients we found an association between a high percentage of circulating CD8+ CD57+ T cells containing perforin, CMV infection and a low CD4/CD8 ratio, suggesting that CMV may have a major role in the T cell abnormalities described previously in this disease. We also show preliminary evidence that CMV contributes to the previously unexplained severe enteropathy that occurs in about 5% of patients.
- Open Access
- 3 July 2006
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 145 (3) , 420-427
Defective maturation of dendritic cells in common variable immunodeficiency
Monocyte-derived dendritic cells (MdDCs) from many patients with common variable immunodeficiency (CVID) have been shown recently to have reduced expression of surface molecules associated with maturity. Using flow cytometry and confocal microscopy, we now show that this is due to a partial failure to fix Class II DR molecules on the surface during procedures that induce full maturation in vitro in cells from normal subjects. Major histocompatibility complex (MHC) class I, CD86 and CD83 expression were expressed normally, but CD40 was reduced. These abnormalities are unlikely to be due to prior in vivo exposure of monocytes to lipopolysaccharide (LPS), as addition of LPS to monocytes from normal subjects in vitro caused a different pattern of changes. CVID MdDCs retained Class II DR in the cytoplasm during maturation, showed increased internalization of cross-linked Class II DR surface molecules and were unable to polarize DR within a lipid raft at contact sites with autologous lymphocytes. These cells retained some features of monocytes, such as the ability to phagocytose large numbers of fixed yeast and fluorescent carboxylated microspheres and expression of surface CD14. These abnormalities, if reflected in vivo, could compromise antigen presentation and may be a fundamental defect in the mechanism of the antibody deficiency in a substantial subset of CVID patients.
- 3 July 2006
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 145 (3) , 420-427
Open AccessDefective maturation of dendritic cells in common variable immunodeficiency
Monocyte-derived dendritic cells (MdDCs) from many patients with common variable immunodeficiency (CVID) have been shown recently to have reduced expression of surface molecules associated with maturity. Using flow cytometry and confocal microscopy, we now show that this is due to a partial failure to fix Class II DR molecules on the surface during procedures that induce full maturation in vitro in cells from normal subjects. Major histocompatibility complex (MHC) class I, CD86 and CD83 expression were expressed normally, but CD40 was reduced. These abnormalities are unlikely to be due to prior in vivo exposure of monocytes to lipopolysaccharide (LPS), as addition of LPS to monocytes from normal subjects in vitro caused a different pattern of changes. CVID MdDCs retained Class II DR in the cytoplasm during maturation, showed increased internalization of cross-linked Class II DR surface molecules and were unable to polarize DR within a lipid raft at contact sites with autologous lymphocytes. These cells retained some features of monocytes, such as the ability to phagocytose large numbers of fixed yeast and fluorescent carboxylated microspheres and expression of surface CD14. These abnormalities, if reflected in vivo, could compromise antigen presentation and may be a fundamental defect in the mechanism of the antibody deficiency in a substantial subset of CVID patients.